Author of the publication

Wie weit bewegen sich die Schwerpunkte hypoxischer Tumorsubvolumina von HNO-Tumoren unter kombinierter Radiochemotherapie.

, , , , , and . Nuklearmedizin, (2010)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

No persons found for author name Zöphel, Klaus
add a person with the name Zöphel, Klaus
 

Other publications of authors with the same name

Stabilität des Hypoxietracers 18 F-FMISO während sequentieller PET-Untersuchungen bei Patienten mit radiochemotherapierten HNO-Tumoren und Korrelation von funktionellen Tumor-Subvolumina zur Rezidivlokalisation, , , , , , , , , and . Strahlentherapie und Onkologie, (2014)Self-reproduction versus transition rules in ant colonies for medical volume segmentation, , , , and . International Conference on Swarm Intelligence, page 316--323. Springer Berlin Heidelberg Berlin, Heidelberg, (2012)Wie weit bewegen sich die Schwerpunkte hypoxischer Tumorsubvolumina von HNO-Tumoren unter kombinierter Radiochemotherapie., , , , , and . Nuklearmedizin, (2010)Usefulness of voxel-wise Pearson correlation coefficient for reproducibility and repeatability measurements in PET, , , , , and . Nuklearmedizin, (2012)Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer, , , , , , , , , and . Radiotherapy and Oncology, 105 (1): 21--28 (2012)Correlation between FMISO-PET based hypoxia in the primary tumour and in lymph node metastases in locally advanced HNSCC patients, , , , , , , , , and 1 other author(s). Clinical and translational radiation oncology, (2019)Fluor-18-Misonidazol-PET/CT unter kurativ intendierter Radiochemotherapie bei Patienten mit lokal fortgeschrittenen Kopf-Hals-Tumoren (KHT)--eine prospektive Explorationsstudie, , , , , , , , , and . Nuklearmedizin, (2013)FMISO-PET-based lymph node hypoxia adds to the prognostic value of tumor only hypoxia in HNSCC patients, , , , , , , , , and 1 other author(s). Radiotherapy and Oncology, (2019)Zwei oder vier Stunden 18F FMISO-PET in Kopf-Hals-Karzinomen: Wann ist der Bildkontrast am höchsten?, , , , , , , and . Nuklearmedizin, (2011)